
Traxium S 250mg/125mg Injection
Marketer
Novique Life Sciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Traxium S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be under a healthcare provider's direct guidance. Complete the prescribed regimen; premature cessation may compromise efficacy. Missed doses should be avoided. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor might order blood tests and other diagnostics to monitor treatment effectiveness.
Uses of Traxium S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Traxium S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Traxium S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Traxium S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Traxium S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg (Traxium S Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance, optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Traxium S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Traxium S, at a dosage of 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nonetheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Traxius S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Traxius S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is inadvisable if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Traxium S 250mg/125mg Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Traxium S 250mg/125mg Injection, as dose modification may be necessary. Medical advice is recommended. Altering the dosage of Traxium S 250mg/125mg Injection is generally not advised for those with mild to moderate liver dysfunction.
What if you forget to take Traxium S 250mg/125mg Injection :
Omitting a scheduled dose of Traxium S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Traxium S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
